BANGKOK, Sep 5, 2020, The Nation. Thai manufacturers have been urged to tap the opportunity for export of medical products reported by the US Food and Drug Administration (USFDA) as at risk of short supply, The Nation reported.
Somdet Susomboon, director-general of the Department of International Trade Promotion (DITP), said that the USFDA had recently announced a list of 20 products that are at risk of shortage in the country due to the Covid-19 crisis.
“Thailand still has capability of manufacturing some of these products, such as surgical gowns, gloves, ventilators and sterile swabs, therefore it is a great chance for Thai companies to export these products to the US,” he said.
Kwannapha Phiewnin, director of DITP Los Angelis Office, added that Thai manufacturers should study the USFDA’s regulations and products standard guidance by visiting http://www.fda.gov/medicaldevices, to make sure that their products meet the required standard before exporting.
“Fortunately during the Covid-19 situation, the USFDA has relaxed many of the regulations to facilitate imports, so qualified Thai entrepreneurs should find no problem in penetrating the US market,” she said.